Jelle Barentsz
@jellemri.bsky.social
Radiologist revolutionizing prostate cancer imaging. Introduced PI-RADS, global standard for prostate MRI. Changed EU/Dutch guidelines: MRI before biopsy. First non-urologist to win EAU Innovators in Urology Award. 40-year career pushing medical boudaries
The experts are right for PSA based screening, but wrong for risk adapted PSA-MRI screening.
Evidence is piling up that risk adapted-MRI screening significantly decreases overdiagnosis and has at least equal detection of significant PCa.
Furthermore, this screening approach is cost-effective.
Evidence is piling up that risk adapted-MRI screening significantly decreases overdiagnosis and has at least equal detection of significant PCa.
Furthermore, this screening approach is cost-effective.
November 24, 2024 at 12:34 PM
The experts are right for PSA based screening, but wrong for risk adapted PSA-MRI screening.
Evidence is piling up that risk adapted-MRI screening significantly decreases overdiagnosis and has at least equal detection of significant PCa.
Furthermore, this screening approach is cost-effective.
Evidence is piling up that risk adapted-MRI screening significantly decreases overdiagnosis and has at least equal detection of significant PCa.
Furthermore, this screening approach is cost-effective.